Drug Discovery for Parkinson's With Mutations in the GBA Gene

Description

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate Parkinson's disease research and drug development by using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for Parkinson's disease.

Conditions

Parkinson Disease, Gaucher Disease, Healthy, GBA Gene Mutation

Talk to us

Study Overview

On this page

Study Details

Study overview

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate Parkinson's disease research and drug development by using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for Parkinson's disease.

Drug Discovery for Parkinson's With Mutations in the GBA Gene

Drug Discovery for Parkinson's With Mutations in the GBA Gene

Condition
Parkinson Disease
Intervention / Treatment

-

Contacts and Locations

New York

The New York Stem Cell Foundation Research Institute, New York, New York, United States, 10019

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 years or older.
  • * Diagnosis of Parkinson's disease, Gaucher disease, or healthy control.
  • * Must provide written informed consent unless physical limitations preclude signing.
  • * For skin samples collected specifically for this study: history of keloid formation, coagulation disorder, allergy to the anesthetic, or anticoagulation use that precludes sample collection.
  • * For blood samples collected specifically for this study: coagulation disorder or other medical condition(s) that increases the risks associated with blood collection.
  • * For all prospective sample collections: Subjects who refuse to adhere to NYSCF's and/or a collection site's safety protocols will be excluded. Subjects with an AIDS diagnosis and CD4 count of less than 200 cells per microliter (mcL) of blood will be excluded due to increased risk of infection.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

New York Stem Cell Foundation Research Institute,

Laura Andres-Martin, PRINCIPAL_INVESTIGATOR, New York Stem Cell Foundation Research Institute

Study Record Dates

2025-07-15